Product Image

Omega 3 Platinum 2000 mg

Advanced Nutrition by Zahler
4.8
★ ★ ★ ★ ★
(2944 ratings)
EPA (Eicosapentaenoic Acid) 600 mg
Omega-3 1100 mg
Fish Oil 2000 mg
DHA 400 mg
Product Image
Score82
A substantial, balanced EPA and DHA serving is the clear strength. Premium cost is harder to justify because important form and quality details are absent.
How scoring works
Quantity:90 Softgel(s) • (45 servings)
Goals:
Anti-Inflammatory Support
Heart Health
Cardiovascular Support
Joint Health
Metabolism Boost
Mental Focus
Skin Health

Score 82

A substantial, balanced EPA and DHA serving is the clear strength. Premium cost is harder to justify because important form and quality details are absent.
How scoring works
$32.47($0.72 per serving)
iHerb
$ 32.47
Vitacost
$ 32.47
iHerb
$ 32.47
Report prices

Analysis

Two softgels provide 600 mg of EPA, 400 mg of DHA, and 1,100 mg of total omega-3 fats. The balanced EPA-led profile offers substantial maintenance depth across several common omega-3 goals.

Active quantities are clearly separated from the 2,000 mg fish-oil amount. Molecular form, fish species, antioxidant protection, and independent purity verification are not supplied, leaving several quality questions unresolved.

The formula suits adults who want meaningful amounts of both EPA and DHA rather than an extreme ratio. Its premium serving cost is difficult to judge favorably without stronger sourcing or testing documentation.

Who is it for
  • Adults seeking substantial EPA and DHA
  • Users wanting a balanced daily omega-3
  • People comfortable taking two softgels
Best for
  • Broad cardiovascular support
  • Combined EPA and DHA intake
  • Moderately high-potency routines

Pros

  • Provides 600 mg EPA and 400 mg DHA
  • Supplies 1,100 mg total omega-3
  • Balanced EPA-led ratio
  • Clear active quantities

Cons

  • Premium serving cost
  • Molecular form is not stated
  • Fish source is not identified
  • No antioxidant or independent purity details
  • Requires two softgels

Warnings

  • Contains fish oil and is not suitable for people with a fish allergy
  • Fish oil may cause fishy aftertaste, reflux, or digestive discomfort in sensitive users
  • The substantial EPA and DHA amount may be relevant for people using anticoagulant or antiplatelet medicines

Nutrient quality

87 Highest impact

Generic fish oil in softgels with an unspecified molecular form gives the formula reasonable ingredient quality. The disclosed amounts are meaningful and the ingredient selection stays focused.

Ingredient transparency

84 Highest impact

Important active details are incomplete or internally inconsistent. Serving guidance and the complete inactive-ingredient list are not fully supplied.

Customer satisfaction

72 High impact

The aggregate rating is strong and supported by useful review volume. No review excerpts are supplied to assess repeated complaints or purpose-specific experiences.

Value for money

85 Highest impact

Formula quality provides fair value for the category. Serving value is reasonable, with trade-offs in delivery or disclosure.

Report analysis

Goals

Anti-Inflammatory Support
Impact
Highest effect
A+ Goal FitA- Strength of SupportC CoverageA+ Formula Quality
Fish Oil · 2000 mg

A clearly quantified combination of EPA and DHA provides strong support for resolving inflammatory signaling. The active amount is suitable for meaningful daily omega-3 support.

The formula is focused, but molecular form, fish source, purification, independent testing, and antioxidant protection are not described. Fish-derived ingredients make it unsuitable for people with fish allergy.

Study evidence
Fish Oil Supportive 68 studies
Heart Health
Impact
Highest effect
A+ Goal FitB+ Strength of SupportB- CoverageA+ Formula Quality
EPA (Eicosapentaenoic Acid) · 600 mg

EPA and DHA directly support lipid management and cardiovascular inflammatory balance. Their combined amount provides a meaningful heart-focused serving.

EPA and DHA amounts are clear, but molecular form and independent purity testing are not disclosed. Fish oil may increase bleeding tendency when combined with anticoagulant or antiplatelet drugs.

Study evidence
Cardiovascular Support
Impact
Highest effect
A+ Goal FitB Strength of SupportB CoverageA+ Formula Quality
Fish Oil · 2000 mg

EPA and DHA directly support triglycerides, endothelial function, and inflammatory balance. Fish oil has strong human evidence for lowering triglycerides and supporting cardiovascular health.

The serving provides 600 mg EPA and 400 mg DHA, a meaningful maintenance amount. EPA and DHA are individually disclosed, but molecular form, purification, oxidation protection, and testing are not stated.

Study evidence
Fish Oil Supportive 185 studies
Joint Health
Impact
High effect
C+ Goal FitB+ Strength of SupportD+ CoverageA+ Formula Quality
Omega-3 · 1100 mg

Clearly disclosed EPA and DHA amounts provide a meaningful omega-3 dose that may support inflammatory balance and joint comfort. The product remains a focused lipid supplement rather than a complete joint formula.

It offers strong depth for one pathway but no cartilage building blocks or direct lubrication support. Transparent fatty-acid amounts and a streamlined design strengthen confidence in the intended use.

Study evidence
Omega-3 Supportive 40 studies
Metabolism Boost
Impact
High effect
C Goal FitA- Strength of SupportD+ CoverageA- Formula Quality
Omega-3 · 1100 mg

EPA and DHA may support insulin sensitivity and metabolic health indirectly. Human evidence is useful for cardiometabolic markers, but omega-3 fats do not directly stimulate thermogenesis.

The 1100 mg total omega-3 amount, including 600 mg EPA and 400 mg DHA, provides a substantial dose. EPA, DHA, and total omega-3 amounts are clearly disclosed, though the oil form is not specified. The oil comes from fish and may not be suitable for people with a fish allergy.

Study evidence
Omega-3 Supportive 42 studies
Mental Focus
Impact
High effect
C- Goal FitB- Strength of SupportC- CoverageA+ Formula Quality

EPA and DHA provide long-term support for brain membranes and inflammatory balance rather than immediate alertness. The serving supplies a useful fatty-acid amount with an EPA-forward balance.

Exact EPA and DHA amounts are disclosed, but the oil form and independent purity testing are not identified. The focused composition offers good depth in one indirect cognitive pathway.

Study evidence
Skin Health
Impact
High effect
C Goal FitB- Strength of SupportD+ CoverageB+ Formula Quality
Omega-3 · 1100 mg

EPA and DHA may support the skin barrier and help regulate inflammatory signaling. The total omega-3 amount is meaningful and the individual fatty acids are disclosed.

The supplied data do not confirm triglyceride form, third-party purity testing, or oxidation control. No collagen, ceramide, hyaluronic acid, or antioxidant cofactor broadens the skin pathways.

Study evidence
Omega-3 Supportive 35 studies

Ingredients

IngredientAmount per serving
Calories
20 Calorie(s)
Total Fat
2 Gram(s)
Fish Oil
2000 mg
Eicosapentaenoic Acid
600 mg
Docosahexaenoic Acid
400 mg
Total Omega-3 Fatty Acids
1100 mg
Gluten Free Adults 18–50 Kosher Dairy Free
Report overview
D- Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyD+ Value

The serving supplies a solid EPA amount with an EPA-to-DHA balance suited to an EPA-focused choice. EPA makes up a moderate share of the fish oil, while the molecular form and antioxidant protection are not disclosed. The cost per gram of EPA is midrange, and no independent purity verification is identified.

Omega-3 · 1100 mg OverallScore48
F Active Ingredient Quality & BioavailabilityC- Dose, Safety & Label TransparencyB+ Value

Clear EPA and DHA amounts support informed dosing, but the oil molecular form is not disclosed. The active fatty acids make up only half of the fish oil, and no independent purity testing or antioxidant protection is stated. Cost efficiency is favorable for the amount of EPA and DHA delivered.

Fish Oil · 2000 mg OverallScore41
F Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyD+ Value

The serving provides an effective maintenance amount of EPA and DHA with clear individual disclosure. The oil is only moderately concentrated, and its molecular form, purification method, independent testing, and antioxidant protection are not stated. Value is average for the active omega-3 amount, while clearer sourcing and quality controls would strengthen confidence.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
    Song J; Hu M; Li C; Yang B; Ding Q; Wang C; Mao L · Food & function · 2018
    Randomized trial201 participantsAnti-Inflammatory Support forFish Oil
  2. Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
    Lin YL; Wang CL; Chiang TI · Frontiers in nephrology · 2024
    Randomized trial60 participantsAnti-Inflammatory Support forFish Oil
  3. Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
    Yang B; Ren XL; Li ZH; Shi MQ; Ding F; Su KP; Guo XJ; Li D · Food & function · 2020
    Randomized trial77 participantsAnti-Inflammatory Support forFish Oil
  4. The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
    Meng Z; Dong Y; Gao H; Yao D; Gong Y; Meng Q; Zheng T; Cui X; Su X; Tian Y · The Journal of international medical research · 2019
    Randomized trial174 participantsAnti-Inflammatory Support forFish Oil
  5. Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Liu R; Jiang J; Fu Z; Liu C; Yao L; Quan H · Journal of the American Nutrition Association · 2022
    Meta-analysis49 studies pooledAnti-Inflammatory Support forFish Oil
  6. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE · Journal of the American Heart Association · 2020
    Meta-analysis127,477 participants13 studies pooledCardiovascular Support forFish Oil
  7. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsCardiovascular Support forFish Oil
  8. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
    Campbell F; Dickinson HO; Critchley JA; Ford GA; Bradburn M · European journal of preventive cardiology · 2013
    Meta-analysis1,524 participants17 studies pooledCardiovascular Support forFish Oil
  9. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
    Zeng Q; Dong SY; Liu YP; Fu J; Shuai P; Zhao ZM; Li TX · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2017
    Randomized trial422 participantsCardiovascular Support forFish Oil
  10. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X · Nutrients · 2020
    Meta-analysis6 studies pooledCardiovascular Support forFish Oil
  11. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
    Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Saito Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Japan EPA lipid intervention study (JELIS) Investigators · Lancet (London, England) · 2007
    Randomized trial18,645 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  12. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; JELIS Investigators, Japan · Atherosclerosis · 2008
    Randomized trial14,981 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  13. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G · European journal of preventive cardiology · 2024
    Meta-analysis134,144 participants18 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  14. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
    Matsuzaki M; Yokoyama M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y; JELIS Investigators · Circulation journal : official journal of the Japanese Circulation Society · 2009
    Randomized trialHeart Health forEPA (Eicosapentaenoic Acid)
  15. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology · Circulation · 2020
    OtherHeart Health forEPA (Eicosapentaenoic Acid)
  16. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis.
    Berbert AA; Kondo CR; Almendra CL; Matsuo T; Dichi I · Nutrition (Burbank, Los Angeles County, Calif.) · 2005
    Randomized trial43 participantsJoint Health forOmega-3
  17. Krill oil improved osteoarthritic knee pain in adults with mild to moderate knee osteoarthritis: a 6-month multicenter, randomized, double-blind, placebo-controlled trial.
    Stonehouse W; Benassi-Evans B; Bednarz J; Vincent AD; Hall S; Hill CL · The American journal of clinical nutrition · 2022
    Randomized trial235 participantsJoint Health forOmega-3
  18. Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Wang W; Xu Y; Zhou J; Zang Y · Clinical rheumatology · 2024
    Meta-analysis1,018 participants18 studies pooledJoint Health forOmega-3
  19. Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis.
    Sigaux J; Mathieu S; Nguyen Y; Sanchez P; Letarouilly JG; Soubrier M; Czernichow S; Flipo RM; Sellam J; Daïen C · Arthritis research & therapy · 2022
    Meta-analysis1,420 participants30 studies pooledJoint Health forOmega-3
  20. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain.
    Goldberg RJ; Katz J · Pain · 2007
    Meta-analysis17 studies pooledJoint Health forOmega-3
  21. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
    Suh SW; Lim E; Burm SY; Lee H; Bae JB; Han JW; Kim KW · BMC medicine · 2024
    Meta-analysis9,660 participants24 studies pooledMental Focus forEPA (Eicosapentaenoic Acid)
  22. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.
    Gustafsson PA; Birberg-Thornberg U; Duchén K; Landgren M; Malmberg K; Pelling H; Strandvik B; Karlsson T · Acta paediatrica (Oslo, Norway : 1992) · 2011
    Randomized trial92 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  23. Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?
    Amza M; Haj Hamoud B; Sima RM; Dinu MD; Gorecki GP; Popescu M; Gică N; Poenaru MO; Pleș L · Biomedicines · 2024
    Narrative reviewMental Focus forEPA (Eicosapentaenoic Acid)
  24. Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.
    Patan MJ; Kennedy DO; Husberg C; Hustvedt SO; Calder PC; Khan J; Forster J; Jackson PA · The American journal of clinical nutrition · 2021
    Randomized trial310 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  25. Effects of omega-3 supplementation on glucose and lipid metabolism in patients with gestational diabetes: A meta-analysis of randomized controlled trials.
    Liu W; Gao M; Yang S; Sun C; Bi Y; Li Y; Wang J; Yuan X · Journal of diabetes and its complications · 2023
    Meta-analysis331 participants6 studies pooledMetabolism Boost forOmega-3
  26. Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism.
    Green CJ; Pramfalk C; Charlton CA; Gunn PJ; Cornfield T; Pavlides M; Karpe F; Hodson L · BMJ open diabetes research & care · 2021
    Randomized trial38 participantsMetabolism Boost forOmega-3
  27. Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
    Soleimani Z; Hashemdokht F; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z · Journal of diabetes and its complications · 2018
    Randomized trial60 participantsMetabolism Boost Skin Health forOmega-3
  28. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Mirmasoumi G; Fazilati M; Foroozanfard F; Vahedpoor Z; Mahmoodi S; Taghizadeh M; Esfeh NK; Mohseni M; Karbassizadeh H; Asemi Z · Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association · 2018
    Randomized trial60 participantsMetabolism Boost forOmega-3
  29. A combination of omega-3 and plant sterols regulate glucose and lipid metabolism in individuals with impaired glucose regulation: a randomized and controlled clinical trial.
    Wang JF; Zhang HM; Li YY; Xia S; Wei Y; Yang L; Wang D; Ye JJ; Li HX; Yuan J; Pan RR · Lipids in health and disease · 2019
    Randomized trial200 participantsMetabolism Boost forOmega-3
  30. Dietetic intervention in psoriatic arthritis: the DIETA trial.
    Leite BF; Morimoto MA; Gomes CMF; Klemz BNC; Genaro PS; Shivappa N; Hébert JR; Damasceno NRT; Pinheiro MM · Advances in rheumatology (London, England) · 2022
    Randomized trial97 participantsSkin Health forOmega-3
  31. Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial.
    Miura K; Vail A; Chambers D; Hopkins PM; Ferguson L; Grant M; Rhodes LE; Green AC · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2019
    Randomized trial49 participantsSkin Health forOmega-3
  32. Treatment of hard-to-heal wounds in ischaemic lower extremities with a novel fish skin-derived matrix.
    Lee YJ; Han HJ; Shim HS · Journal of wound care · 2024
    Randomized trial50 participantsSkin Health forOmega-3
  33. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.
    Rhodes LE; Shahbakhti H; Azurdia RM; Moison RM; Steenwinkel MJ; Homburg MI; Dean MP; McArdle F; Beijersbergen van Henegouwen GM; Epe B; Vink AA · Carcinogenesis · 2003
    Randomized trial42 participantsSkin Health forOmega-3